Physiologic parameters:
Body temperature |
36.5-38.0° C |
Heart rate |
325-780/min |
Respiratory rate |
94-163/min |
Tidal volume |
0.09-0.23 ml |
The use of chloroform as an anesthetic agent is discouraged.
Chloroform can cause renal tubular calcification
and/or necrosis, particularly in male mice; the DBA/2
strain is the most susceptible.
Avertin is made by mixing equal amounts of tribromyl
ethyl alcohol and tertiary amyl alcohol, then diluted
to 2.5% in water or saline. Avertin has toxic degradation
products, therefore, only a freshly mixed solution should
be used. The 2.5% solution must be stored at 4°C in the
dark. The pH of the 2.5% solution must be above 5.
The therapeutic dose for carbon dioxide is close to the
lethal dose. Carbon dioxide is very short acting. Carbon
dioxide must be administered from a tank equipped with
a regulator–dry ice is not acceptable.
Postoperative Analgesia For Rodents
Analgesia is required for rodents after surgery, unless
there is scientific justification for withholding pain
relief. Two procedures for providing analgesia to rodents
are described below. The use of Marcaine is recommended
for pain relief immediately after surgery. Long-lasting
pain relief can be provided with buprenorphine.
Marcaine
Marcaine (bupivacaine) injected subcutaneously at the
incision site(s) provides 8-10 hours of post surgical
local anesthesia:
* Purchase 0.25% Marcaine (catalogue number #6310567
Marcaine vials 30 ml 0.25% 10/Bx $53.69/Bx Phone/Fax 800-772-4346/800-329-9109 http://www.henryschein.com/)
* Dilute 1:10 in sterile water, saline or PBS and inject
0.1 ml/25 g mouse subcutaneously at the incision site.
Buprenorphine
Pain relief for more extended periods can be provided
with buprenorphine (Buprenex). It should be noted that
buprenorphine is a narcotic analgesic. All narcotic analgesics
depress respiration to some extent and should not be administered
to an animal that is already under anesthesia with an
injectable agent which cannot be reversed. Depressive
effects of anesthetics, analgesics, tranquilizers and
sedatives are additive and should be taken into account
when they are used together. If buprenorphine is used
for anesthetic induction, the dose of anesthesia must
be reduced by 10-25%. Alternatively, wait until the animal
is completely recovered from anesthesia before administering.
It is recommended that the appropriate dosage be established
in advance for the strain of rodent you are anesthetizing.
* 0.05-0.1 mg/kg IM, SQ or IP administered at least once
immediately after surgery for routine surgeries, and every
12 hours for up to 3 days if the procedure is expected
to result in prolonged pain (e.g. orthopedic procedures).
* To prepare a dilution for smaller rodents, one 1 ml
vial of Buprenex (0.3 mg) is drawn into a sterile syringe
and added to 19 ml of sterile 5% dextrose in water or
0.9 % NaCl and dispensed into a sterile vial (e.g. a sterile
serum tube). Label the tube "Buprenorphine HCl, 0.015
mg/ml" and the date prepared. Expiration date is either
that from the original package, or 6 months from the date
prepared. Protect from light.
* Administer 0.06-0.13 ml to an average 20 g mouse, 0.6-1.3
ml per average 200 g rat. There is a wide range of safety
and efficacy for this drug. It is not necessary to weigh
mice prior to administration and doses may be doubled
if clinical efficacy is not apparent.
* Following an initial parenteral dose (see above), subsequent
doses of buprenorphine may be given enterally at 0.5 mg/kg
administered twice daily in Jello.
Buprenorphine Jello
Species |
Drug amount |
Volume Water |
Cube Volume Per Animal |
Mouse |
1 ml vial (0.3 mg) |
15 ml |
1 ml |
Rat |
1 ml vial (0.3 mg) |
3 ml |
4 ml |
Restraint/Preanesthesia
| Indication and Drugs |
Dosage and Route of Administration |
Atropine |
0.04 mg/kg |
IM |
Diazepam, C-IV (Valium®) |
0.5 mg/100 g |
IP |
Ketamine (10 mg/ml) |
2.2-4.4 mg/100 g |
IM |
Ketamine/Acetylpromazine (10:1, dose based on ketamine) |
2.2-4.4 mg/100 g |
IM |
Sodium Pentobarbital, C-II |
3-4 mg/100 g |
IP |
Carbon dioxide |
To effect |
IH |
Anesthesia
| Indication and Drugs |
Dosage and Route of Administration |
Sodium Pentobarbital, C-II |
5-9 mg/100 g |
IP |
Ketamine (Ketaset® or Vetalar®) |
5-20 mg/100 g |
IP |
| |
4-6 mg/100 g |
IM |
Avertin (Tribromoethanol) |
0.3-0.6 mg/g |
IP |
Ketamine/Xylazine: |
|
|
- Add 7 mg
xylazine to 35 mg ketamine (dose based on ketamine) |
7-8 mg/100 g |
IM IP |
- Add 1.0 ml
xylazine (100 mg/ml) and 1.0 ml ketamine (100 mg/ml)
and 4.6 ml sterile water. |
0.1 ml/20 g |
IM IP |
Methoxyflurane (Metofane®) |
To effect |
IH |
Halothane (Fluothane®) |
To effect |
IH |
Isoflurane |
To effect |
IH |
Carbon dioxide |
To effect |
IH |
Telazol® |
10-16 mg/100 g |
IP IM |
Analgesia
| Indication and Drugs |
Dosage and Route of Administration |
Morphine, C-II |
0.5-1.0 mg/100 g q2-4h |
SC IP |
Meperidine, C-II (Demerol®) |
0.2-0.4 mg/100 g |
IP |
Pentazocine, C-IV (Talwin®) |
0.3-1.0 mg/100 g q3-4h |
IM |
Butorphanol tartrate (Torbugesic®) |
0.25-0.5 mg/100 g q1-2h |
SC |
Buprenorphine |
0.2 mg/100 g q12h |
SC IP |